Instem PLC (INS)

London
Currency in GBP
830.00
0.00(0.00%)
Closed·
Showing Instem historical data. For real-time data please try another search
Fair Value
Day's Range
830.00830.00
52 wk Range
830.00830.00
Key Statistics
Edit
Prev. Close
830
Open
830
Day's Range
830-830
52 wk Range
830-830
Volume
-
Average Volume (3m)
151.26K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
INS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Instem PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Instem PLC Company Profile

Instem Limited, together with its subsidiaries, provides information technology solutions and services to the life sciences healthcare market worldwide. It offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. The company also provides computational toxicology products and services; Blur Clinical Annonymization; Logbook ELN, a repository for information; Morphit for discovery data visualization; NOTOCORD-hem software platforms to acquire, display, and analyze physiological signals; and Provantis, a windows-based system for non-clinical evaluation studies. In addition, it provides Samarind RMS to manage medical product information; submit platform that offers tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; SENDView, an application that simplifies the review of SEND datasets; KnowledgeScan Target Safety Assessment services; SENDTrial, a web based solution that can be accessed through a subscription; and Predict delivers computational models. Further, the company provides Sorcerer Colony Counter; sales and administrative support; training, validation, consultancy, cloud, and safety assessment and regulatory information management software services; software solutions to extract intelligence from research and development related healthcare data; and holds intellectual property rights and investment. It also develops, manufactures, and supplies software and hardware products for in vitro study data collection and management. The company was founded in 1969 and is headquartered in Stone, United Kingdom.

Employees
510

Instem PLC Earnings Call Summary for Q4/2024

  • Sales surged 56% YoY; adjusted earnings at €36.9M, within guided range; strong €100M+ operating cash flow
  • Proposed dividend of €0.26/share; net debt to EBITDA improved to 2.1x; gross margin steady at 22.6%
  • 2025 outlook: sales volume over €500M; revenue €350-400M; adjusted earnings €25-35M; gross margin ~23%
  • CEO: "passed bottom of cycle"; CFO highlights cost management; €4B potential project pipeline
  • Risks: supply chain issues, rising rates, market saturation; institutional market recovery expected H2 2025
Last Updated: 2025-03-18, 12:08 p/m
Read Full Transcript

Compare INS to Peers and Sector

Metrics to compare
INS
Peers
Sector
Relationship
P/E Ratio
UnlockNaNNaNUnlock
PEG Ratio
UnlockNaNNaNUnlock
Price/Book
UnlockNaNNaNUnlock
Price / LTM Sales
UnlockNaNNaNUnlock
Upside (Analyst Target)
UnlockNaNNaNUnlock
Fair Value Upside
UnlockNaNNaNUnlock

Earnings

Latest Release
Oct 05, 2024
EPS / Forecast
-0.25 / --
Revenue / Forecast
30.63M / --
EPS Revisions
Last 90 days

INS Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.